Clinical Trials
- Stomach and Esophagus, Pancreatic Cancer, Colorectal Cancer, Phase 1 Cancers
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Advanced or Metastatic Solid Tumors
- Stomach and Esophagus, Head and Neck Cancers, Lung Cancer, Bladder Cancer, Pancreatic Cancer, Phase 1 Cancers
A Phase 1 Open-label Study to Investigate PF-08046876 in Adult Participants With Advanced Solid Tumors
- Pancreatic Cancer
A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma
- Colorectal Cancer, Pancreatic Cancer
A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Pancreatic Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
- Stomach and Esophagus, Liver Cancer, Pancreatic Cancer, Colorectal Cancer
Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Colorectal Cancer, Sarcoma Cancers, Stomach and Esophagus, Kidney Cancer, Head and Neck Cancers, Liver Cancer, Lung Cancer, Gynecological Cancers, Pancreatic Cancer, Prostate Cancer, Thyroid and Other Endocrine Cancers, Breast Cancer
PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
- Thyroid and Other Endocrine Cancers, Pancreatic Cancer
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
- Pancreatic Cancer
The Cancer of the Pancreas Screening-5 (CAPS5) Study
- Ages18 years and older
- GenderBoth